Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

PROCEPT BioRobotics Corporation - Common Stock (NQ:PRCT)

33.84 -2.02 (-5.62%)
Streaming Delayed Price Updated: 10:02 AM EST, Dec 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 624,254
Open 33.62
Bid (Size) 33.75 (600)
Ask (Size) 33.94 (200)
Prev. Close 35.86
Today's Range 33.27 - 35.10
52wk Range 27.80 - 97.49
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
PROCEPT BioRobotics® to Present at Upcoming 37th Annual Piper Sandler Healthcare Conference on December 2, 2025
From PROCEPT BioRobotics
Via GlobeNewswire
News headline image
PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance
From PROCEPT BioRobotics
Via GlobeNewswire

Performance

YTD
-59.3%
-59.3%
1 Month
+6.0%
+6.0%
3 Month
-13.0%
-13.0%
6 Month
-46.2%
-46.2%
1 Year
-63.4%
-63.4%

More News

Read More
News headline image
Earnings Scheduled For November 4, 2025 ↗
Via Benzinga
News headline image
2 Robotics Stocks Riding the Sensor and Medical Boom ↗
Via The Motley Fool
News headline image
Earnings Scheduled For August 6, 2025 ↗
Via Benzinga
News headline image
Where PROCEPT BioRobotics Stands With Analysts ↗
Via Benzinga
News headline image
Earnings Scheduled For April 24, 2025 ↗
Via Benzinga
News headline image
Is Procept BioRobotics Stock a Buy After Investment Company Chicago Capital Scoops Up Nearly 1 Million Shares? ↗
Via The Motley Fool
News headline image
Beyond The Numbers: 4 Analysts Discuss PROCEPT BioRobotics Stock ↗
Via Benzinga
News headline image
PROCEPT BioRobotics® to Report Third Quarter 2025 Financial Results on November 4, 2025
From PROCEPT BioRobotics
Via GlobeNewswire
News headline image
Assessing PROCEPT BioRobotics: Insights From 4 Financial Analysts ↗
Via Benzinga
News headline image
Procept (PRCT) Q2 Revenue Jumps 48% ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
PROCEPT BioRobotics (PRCT) Earnings Transcript ↗
Via The Motley Fool
Topics World Trade
News headline image
PROCEPT BioRobotics Corp. (NASDAQ:PRCT) Reports Q2 2025 Revenue Growth but Misses Profitability Targets, Triggering After-Hours Decline ↗
Via Chartmill
News headline image
PROCEPT BioRobotics Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
From PROCEPT BioRobotics
Via GlobeNewswire
News headline image
Uncovering Potential: PROCEPT BioRobotics's Earnings Preview ↗
Via Benzinga
News headline image
PROCEPT BioRobotics® President and CEO Dr. Reza Zadno to Retire, Company Appoints Larry L. Wood as New President and CEO
From PROCEPT BioRobotics
Via GlobeNewswire
News headline image
Ambulatory Surgery Center Completes WATER IV Trial Procedures for Prostate Cancer with Aquablation® Therapy
From PROCEPT BioRobotics
Via GlobeNewswire
News headline image
PROCEPT BioRobotics® to Report Second Quarter 2025 Financial Results on August 6, 2025
From PROCEPT BioRobotics
Via GlobeNewswire
News headline image
Aquablation® Therapy’s Assigned Category I Code in 2026 Medicare Proposed Physician Fee Schedule
From PROCEPT BioRobotics
Via GlobeNewswire
News headline image
PROCEPT BioRobotics® to Attend Four Upcoming Investor Conferences in May & June
From PROCEPT BioRobotics
Via GlobeNewswire
News headline image
PROCEPT BioRobotics' Aquablation Therapy Spotlighted at 2025 AUA Annual Meeting Along with Expert-Led Workshops
From PROCEPT BioRobotics
Via GlobeNewswire
News headline image
PROCEPT BioRobotics Reports First Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
From PROCEPT BioRobotics
Via GlobeNewswire
News headline image
PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting at the Aria Resort in Las Vegas
From PROCEPT BioRobotics
Via GlobeNewswire
News headline image
WATER III Randomized-Controlled Trial Results Announced at European Association of Urology Comparing Aquablation® Therapy to Laser Enucleation
From PROCEPT BioRobotics
Via GlobeNewswire

Frequently Asked Questions

Is PROCEPT BioRobotics Corporation - Common Stock publicly traded?
Yes, PROCEPT BioRobotics Corporation - Common Stock is publicly traded.
What exchange does PROCEPT BioRobotics Corporation - Common Stock trade on?
PROCEPT BioRobotics Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for PROCEPT BioRobotics Corporation - Common Stock?
The ticker symbol for PROCEPT BioRobotics Corporation - Common Stock is PRCT on the Nasdaq Stock Market
What is the current price of PROCEPT BioRobotics Corporation - Common Stock?
The current price of PROCEPT BioRobotics Corporation - Common Stock is 33.84
When was PROCEPT BioRobotics Corporation - Common Stock last traded?
The last trade of PROCEPT BioRobotics Corporation - Common Stock was at 12/08/25 10:02 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.